title: Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
authors.affiliation: National Center for Toxicological Research, US Food and Drug Administration, Rockville, MD, USA. S.Tabacova@nctr.fda.gov
authors.forename: Sonia A
authors.initials: SA
authors.lastname: Tabacova
authors.forename: Carole A
authors.initials: CA
authors.lastname: Kimmel
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D001262:Atenolol / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001262:Atenolol